Table 2.
Anthropometric measurements, metabolic, and adipokines serum levels among all groups.
| Premenopause | Postmenopause | |||
|---|---|---|---|---|
| Healthy control | Breast cancer | Healthy control | Breast cancer | |
| (n = 27) | (n = 44) | (n = 41) | (n = 38) | |
| Age (years) | 35.22 ± 7.59 | 43.68 ± 6.07a | 63.46 ± 10.04 | 65.26 ± 11.34a |
| BMI (kg/m2) | 23.72 ± 1.26 | 24.04 ± 1.24 | 24.22 ± 1.42 | 24.92 ± 1.51 |
| WC (cm) | 76.71 ± 2.91 | 76.21 ± 3.39 | 76.09 ± 3.15 | 79.05 ± 2.59a |
| SBP (mmHg) | 123.29 ± 9.31 | 124.43 ± 7.42 | 125.78 ± 9.08 | 131.10 ± 12.42a |
| DBP (mmHg) | 77.37 ± 8.0 | 79.11 ± 9.06 | 82.73 ± 5.44 | 86.11 ± 10.40a |
| Glucose (mg/dL) | 88.02 ± 10.39 | 88.80 ± 12.51 | 98.56 ± 11.68 | 98.60 ± 12.51 |
| TG (mg/dL) | 118.27 ± 29.97 | 151.50 ± 19.60 | 126.57 ± 25.37 | 153.88 ± 26.20 |
| TC (mg/dL) | 189.14 ± 23.17 | 204.52 ± 23.82 | 194.76 ± 12.718 | 224.52 ± 30.82 |
| LDLc (mg/dL) | 121.56 ± 19.55 | 142.94 ± 23.27 | 137.93 ± 23.49 | 147.52 ± 18.82 |
| HDLc (mg/dL) | 44.81 ± 5.37 | 39.91 ± 4.83 | 45.90 ± 5.41 | 40.89 ± 3.78 |
| Leptin (ng/mL) | 19.52 ± 2.93 | 20.32 ± 1.87 | 19.68 ± 1.19 | 29.52 ± 4.17 |
| Adiponectin (mg/L) | 10.86 ± 1.67 | 9.92 ± 0.62 | 11.01 ± 1.58 | 6.74 ± 1.92 |
| Resistin (μg/L) | 24.15 ± 1.24 | 25.21 ± 1.54 | 21.73 ± 2.79 | 27.14 ± 1.79 |
| Visfatin (ng/mL) | 15.03 ± 2.91 | 16.96 ± 1.99 | 15.26 ± 2.41 | 21.20 ± 3.62 |
a P < 0.05 as calculated by ANOVA t-test versus respective controls (between premenopausal healthy control and premenopausal BC patients and between postmenopausal healthy control and postmenopausal BC patients).